Virios Therapeutics, Inc. (VIRI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.1M |
| Enterprise Value | 15.58M |
| P/E Ratio | 0.13 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.06 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 127.52 |
| Return On Equity | 286.25 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 54.44M |
| Net Income | -35.51M |
| Diluted EPS | -7.13 |
Balance Sheet
| Total Cash | 13.23M |
| Total Cash/Share | 0.39 |
| Total Debt | 144,930 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.86 |
| Book Value Per Share | 2.4 |
Price History
| 52-Week Change | -99.11 |
| 52-Week High | 26 |
| 52-Week Low | 0.14 |
| Moving Average 50 Days | 4.51 |
| Moving Average 200 Days | 7.69 |
Statistics
| Average Volume | 87,787 |
| Shares Outstanding | 1.33M |
| % Held by Institutions | 7.69 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
